Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
US10875864B2 · kind B2 · utility
1Cited by
51References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2019 |
| Grant date | Dec 29, 2020 |
| Priority date | — |
| Expiry date | Jul 2, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound having the following structure: Compositions and methods for using the same in the treatment of skin disorders and other Pim kinase-associated conditions are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.